Otulfi 45 mg

OTULFI 45 MG is a subcutaneous solution containing ustekinumab, used for managing specific inflammatory conditions. This medication is designed to help reduce symptoms and improve quality of life.

OTULFI 45 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. It may also be prescribed for other inflammatory conditions as determined by a healthcare provider. The active ingredient, ustekinumab, works by targeting specific proteins in the body to reduce inflammation.

Common effects of OTULFI 45 MG may include redness, itching, or swelling at the injection site. Some individuals might experience headaches, fatigue, or mild upper respiratory infections. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare professional.

OTULFI 45 MG should be used with caution in individuals with a history of serious infections or allergic reactions to ustekinumab or similar medications. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Always inform your healthcare professional about any other medications you are taking to avoid potential interactions.

OTULFI 45 MG may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to ensure safe use. Avoid alcohol while using this medication, as it may increase the risk of side effects.